Private Advisor Group LLC Decreases Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Private Advisor Group LLC cut its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 14.4% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 43,835 shares of the pharmacy operator’s stock after selling 7,345 shares during the period. Private Advisor Group LLC’s holdings in Walgreens Boots Alliance were worth $530,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also made changes to their positions in the company. Pineridge Advisors LLC purchased a new stake in Walgreens Boots Alliance in the 4th quarter valued at $26,000. Quest Partners LLC acquired a new position in shares of Walgreens Boots Alliance during the 4th quarter valued at about $30,000. 1832 Asset Management L.P. grew its holdings in shares of Walgreens Boots Alliance by 282.1% in the fourth quarter. 1832 Asset Management L.P. now owns 1,219 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 900 shares during the period. New Covenant Trust Company N.A. acquired a new stake in Walgreens Boots Alliance during the first quarter worth about $35,000. Finally, First Personal Financial Services raised its stake in Walgreens Boots Alliance by 260.0% during the first quarter. First Personal Financial Services now owns 1,800 shares of the pharmacy operator’s stock worth $39,000 after purchasing an additional 1,300 shares during the period. 58.59% of the stock is currently owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Price Performance

Shares of WBA opened at $9.01 on Thursday. The company has a quick ratio of 0.31, a current ratio of 0.65 and a debt-to-equity ratio of 0.49. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.46 and a fifty-two week high of $27.05. The company has a market cap of $7.78 billion, a P/E ratio of -1.34, a PEG ratio of 1.02 and a beta of 0.70. The firm’s 50 day moving average price is $10.40 and its 200 day moving average price is $14.89.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.68 by ($0.05). Walgreens Boots Alliance had a negative net margin of 3.99% and a positive return on equity of 12.63%. The company had revenue of $36.40 billion during the quarter, compared to analyst estimates of $35.94 billion. During the same quarter in the previous year, the business posted $1.00 earnings per share. The firm’s revenue was up 2.8% on a year-over-year basis. On average, research analysts forecast that Walgreens Boots Alliance, Inc. will post 2.86 earnings per share for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, September 12th. Stockholders of record on Wednesday, August 21st were given a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 11.10%. The ex-dividend date was Wednesday, August 21st. Walgreens Boots Alliance’s dividend payout ratio is presently -14.84%.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the stock. Morgan Stanley dropped their price target on shares of Walgreens Boots Alliance from $13.00 to $9.00 and set an “underweight” rating for the company in a research note on Friday, June 28th. TD Cowen lowered their price objective on Walgreens Boots Alliance from $22.00 to $16.00 and set a “buy” rating for the company in a research report on Thursday, September 12th. Barclays reduced their target price on Walgreens Boots Alliance from $11.00 to $7.00 and set an “underweight” rating on the stock in a research report on Tuesday, July 23rd. UBS Group lowered their price target on Walgreens Boots Alliance from $17.00 to $12.00 and set a “neutral” rating for the company in a report on Wednesday, July 3rd. Finally, Truist Financial reduced their price objective on shares of Walgreens Boots Alliance from $20.00 to $13.00 and set a “hold” rating on the stock in a report on Friday, June 28th. Four equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, Walgreens Boots Alliance has a consensus rating of “Hold” and a consensus target price of $14.73.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.